{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:15:28Z","timestamp":1787238928443,"version":"build-2736575974"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Redes de Investigaci\u00f3n Cooperativa Orientadas a Resultados en Salud"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19) and SSc share multiple similarities in their clinical manifestations, alterations in immune response and therapeutic options. These resemblances have also been identified in other immune-mediated inflammatory diseases where a common genetic component has been found. Thus, we decided to evaluate for the first time this shared genetic architecture with SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>For this study, we retrieved genomic data from two European-ancestry cohorts: 2\u2009597\u2009856 individuals from The COVID-19 Host Genetics Initiative consortium, and 26\u2009679 individuals from the largest genomic scan in SSc. We performed a cross-trait meta-analyses including &amp;gt;9.3 million single nucleotide polymorphisms. Finally, we conducted functional annotation to prioritize potential causal genes and performed drug repurposing analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results revealed a total of 19 non-HLA pleiotropic loci, including 2 novel associations for both conditions (BMP1 and PPARG) and 12 emerging as new shared loci. Functional annotation of these regions underscored their potential regulatory role and identified potential causal genes, many of which are implicated in fibrotic and inflammatory pathways. Remarkably, we observed an antagonistic pleiotropy model of the IFN signalling between COVID-19 and SSc, including the well-known TYK2 P1104A missense variant, showing a protective effect for SSc while being a risk factor for COVID-19, along with two additional novel pleiotropic associations (IRF8 and SENP7). Finally, our findings provide new therapeutic options that could potentially benefit both conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study confirms the genetic resemblance between susceptibility to and severity of COVID-19 and SSc, revealing a novel common genetic contribution affecting fibrotic and immune pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf028","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:15:38Z","timestamp":1737962138000},"page":"4022-4031","source":"Crossref","is-referenced-by-count":2,"title":["Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation pathways"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1257-3338","authenticated-orcid":false,"given":"Carlos","family":"Rosa-Baez","sequence":"first","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-2884","authenticated-orcid":false,"given":"Gonzalo","family":"Borrego-Yaniz","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-1581","authenticated-orcid":false,"given":"Inmaculada","family":"Rodriguez-Martin","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-4514","authenticated-orcid":false,"given":"Martin","family":"Kerick","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-6535","authenticated-orcid":false,"given":"Marialbert","family":"Acosta-Herrera","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]},{"name":"Systemic Autoimmune Disease Unit, Hospital Cl\u00ednico San Cecilio, Instituto de Investigaci\u00f3n Biosanitaria Ibs. GRANADA , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-0622","authenticated-orcid":false,"given":"Javier","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0247-4280","authenticated-orcid":false,"given":"Lourdes","family":"Ortiz-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine L\u00f3pez-Neyra, CSIC , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"2025052703521468800_keaf028-B1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"key":"2025052703521468800_keaf028-B2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/annrheumdis-2021-221366","article-title":"2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19","volume":"81","author":"Alunno","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025052703521468800_keaf028-B3","first-page":"e00299","article-title":"Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis","volume":"34","author":"Ramasamy","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"2025052703521468800_keaf028-B4","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"key":"2025052703521468800_keaf028-B5","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2025052703521468800_keaf028-B6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet (London, England)"},{"key":"2025052703521468800_keaf028-B7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.42030","article-title":"SARS\u2013CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and meta-analysis","volume":"74","author":"Conway","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025052703521468800_keaf028-B8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12016-015-8505-8","article-title":"T and NK cell phenotypic abnormalities in systemic sclerosis: a cohort study and a comprehensive literature review","volume":"49","author":"Almeida","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025052703521468800_keaf028-B9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41584-022-00864-7","article-title":"Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis","volume":"18","author":"Fang","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025052703521468800_keaf028-B10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","article-title":"Systemic sclerosis interstitial lung disease: unmet needs and potential solutions","volume":"20","author":"Liakouli","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"2025052703521468800_keaf028-B11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S2213-2600(23)00159-5","article-title":"Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025052703521468800_keaf028-B12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41586-023-06034-3","article-title":"GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19","volume":"617","author":"Pairo-Castineira","year":"2023","journal-title":"Nature"},{"key":"2025052703521468800_keaf028-B13","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe covid-19 with respiratory failure","volume":"383","author":"Ellinghaus","year":"2020","journal-title":"N Engl J Med"},{"key":"2025052703521468800_keaf028-B14","doi-asserted-by":"crossref","first-page":"e28570","DOI":"10.1002\/jmv.28570","article-title":"Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bidirectional Mendelian randomization study","volume":"95","author":"Yao","year":"2023","journal-title":"J Med Virol"},{"key":"2025052703521468800_keaf028-B15","doi-asserted-by":"crossref","first-page":"e1010253","DOI":"10.1371\/journal.pgen.1010253","article-title":"COVID-19 and systemic lupus erythematosus genetics: a balance between autoimmune disease risk and protection against infection","volume":"18","author":"Wang","year":"2022","journal-title":"PLoS Genet"},{"key":"2025052703521468800_keaf028-B16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41431-020-0636-6","article-title":"The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic","volume":"28","author":"COVID-19 Host Genetics Initiative","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"2025052703521468800_keaf028-B17","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat Commun"},{"key":"2025052703521468800_keaf028-B18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2025052703521468800_keaf028-B19","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2025052703521468800_keaf028-B20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"2025052703521468800_keaf028-B21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"2025052703521468800_keaf028-B22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200606058","article-title":"BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein","volume":"175","author":"Ge","year":"2006","journal-title":"J Cell Biol"},{"key":"2025052703521468800_keaf028-B23","doi-asserted-by":"crossref","first-page":"2201799","DOI":"10.1183\/13993003.01799-2022","article-title":"Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis","volume":"61","author":"Wu","year":"2023","journal-title":"Eur Respir J"},{"key":"2025052703521468800_keaf028-B24","doi-asserted-by":"crossref","first-page":"e13778","DOI":"10.1371\/journal.pone.0013778","article-title":"PPAR\u03b3 downregulation by TGF\u00df in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis","volume":"5","author":"Wei","year":"2010","journal-title":"PLoS One"},{"key":"2025052703521468800_keaf028-B25","doi-asserted-by":"crossref","first-page":"102510","DOI":"10.1016\/j.jaut.2020.102510","article-title":"The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review","volume":"113","author":"Liu","year":"2020","journal-title":"J Autoimmun"},{"key":"2025052703521468800_keaf028-B26","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1136\/annrheumdis-2016-210821","article-title":"Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension","volume":"76","author":"Avouac","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025052703521468800_keaf028-B27","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1136\/annrheumdis-2015-208029","article-title":"Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis","volume":"75","author":"Ruzehaji","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025052703521468800_keaf028-B28","doi-asserted-by":"crossref","first-page":"164134","DOI":"10.1155\/2008\/164134","article-title":"Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure","volume":"2008","author":"Elias","year":"2008","journal-title":"Mediators Inflamm"},{"key":"2025052703521468800_keaf028-B29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-023-00966-w","article-title":"Matrix metalloproteinases in arthritis: towards precision medicine","volume":"19","author":"Grillet","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025052703521468800_keaf028-B30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"2025052703521468800_keaf028-B31","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"2025052703521468800_keaf028-B32","doi-asserted-by":"crossref","first-page":"363ra149","DOI":"10.1126\/scitranslmed.aag1974","article-title":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity","volume":"8","author":"Dendrou","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025052703521468800_keaf028-B33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.adg2992","article-title":"Common genetic factors among autoimmune diseases","volume":"380","author":"Harroud","year":"2023","journal-title":"Science"},{"key":"2025052703521468800_keaf028-B34","doi-asserted-by":"crossref","first-page":"100248","DOI":"10.1016\/j.xgen.2022.100248","article-title":"Genetic adaptation to pathogens and increased risk of inflammatory disorders in post-Neolithic Europe","volume":"3","author":"Kerner","year":"2023","journal-title":"Cell Genomics"},{"key":"2025052703521468800_keaf028-B35","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2025052703521468800_keaf028-B36","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2025052703521468800_keaf028-B37","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025052703521468800_keaf028-B38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025052703521468800_keaf028-B39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028423","article-title":"The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family","volume":"10","author":"Negishi","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2025052703521468800_keaf028-B40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/annrheumdis-2018-214127","article-title":"Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases","volume":"78","author":"Acosta-Herrera","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025052703521468800_keaf028-B41","doi-asserted-by":"crossref","first-page":"e42104","DOI":"10.1371\/journal.pone.0042104","article-title":"Tagging single nucleotide polymorphisms in the IRF1 and IRF8 genes and tuberculosis susceptibility","volume":"7","author":"Ding","year":"2012","journal-title":"PLoS One"},{"key":"2025052703521468800_keaf028-B42","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood-2014-04-570879","article-title":"Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation","volume":"124","author":"Salem","year":"2014","journal-title":"Blood"},{"key":"2025052703521468800_keaf028-B43","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.jaci.2017.08.044","article-title":"Biallelic interferon regulatory factor 8 mutation: a complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation","volume":"141","author":"Bigley","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025052703521468800_keaf028-B44","doi-asserted-by":"crossref","first-page":"758190","DOI":"10.3389\/fimmu.2021.758190","article-title":"Mutation in Irf8 gene (Irf8R294C) impairs type I IFN-mediated antiviral immune response by murine pDCs","volume":"12","author":"Das","year":"2021","journal-title":"Front Immunol"},{"key":"2025052703521468800_keaf028-B45","doi-asserted-by":"crossref","first-page":"e1006156","DOI":"10.1371\/journal.ppat.1006156","article-title":"SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing","volume":"13","author":"Cui","year":"2017","journal-title":"PLoS Pathog"},{"key":"2025052703521468800_keaf028-B46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","article-title":"Refining the impact of genetic evidence on clinical success","volume":"629","author":"Minikel","year":"2024","journal-title":"Nature"},{"key":"2025052703521468800_keaf028-B47","doi-asserted-by":"crossref","first-page":"106642","DOI":"10.1016\/j.phrs.2022.106642","article-title":"Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis","volume":"189","author":"Roskoski","year":"2023","journal-title":"Pharmacol Res"},{"key":"2025052703521468800_keaf028-B48","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"2025052703521468800_keaf028-B49","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/rheumatology\/keaa613","article-title":"Tofacitinib as a possible treatment for skin thickening in diffuse cutaneous systemic sclerosis","volume":"60","author":"You","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025052703521468800_keaf028-B50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159566","article-title":"Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial","volume":"7","author":"Khanna","year":"2022","journal-title":"JCI insight"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf028\/61683656\/keaf028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/4022\/61683656\/keaf028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/4022\/61683656\/keaf028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:52:23Z","timestamp":1748317943000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/6\/4022\/7989306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,1,29]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf028","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,1,29]]}}}